" At $1,000 per test, that creates a potential $3.0 billion opportunity for LymPro once final commercial approval is granted. Under CLIA, the opportunity looks to be at least $100 million."
(0)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.
